To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

OTA 2020: Assessing Venous Thromboembolism in Hip Fracture - Sub-analysis of FAITH and HEALTH Trials

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2020

OTA 2020: Assessing Venous Thromboembolism in Hip Fracture - Sub-analysis of FAITH and HEALTH Trials

Vol: 9| Issue: 10| Number:31| ISSN#: 2564-2537
Study Type:N/A
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Venous Thromboembolism in Hip Fracture Patients: A Subanalysis of the FAITH and HEALTH Trials

Contributing Authors:
D Macdonald D Neilly P Schneider S Bzovsky S Sprague D Axelrod RW Poolman F Frihagen M Bhandari M Swiontkowski E Schemitsch I Stevenson The HEALTH Investigators FAITH investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

A total of 2520 patients in the FAITH and HEALTH trials with hip fractures were included in this sub-analysis assessing the incidence of venous thromboembolism (VTE) and factors associated with VTE. The primary outcome of interest was the incidence of VTE in the hip fracture population. Secondary outcomes of interest included timing of VTE, prophylaxis prescribed, and factors associated with VTE. ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue